Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$8.23B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.46B |
| 3 |
NVIDIA
NVDA
|
+$1.45B |
| 4 |
T-Mobile US
TMUS
|
+$1.41B |
| 5 |
Broadcom
AVGO
|
+$1.38B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$3.04B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$2.7B |
| 3 |
Amazon
AMZN
|
+$2.11B |
| 4 |
Microsoft
MSFT
|
+$2.02B |
| 5 |
Merck
MRK
|
+$1.79B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.15% |
| 2 | Healthcare | 19.44% |
| 3 | Financials | 13.51% |
| 4 | Consumer Discretionary | 9.13% |
| 5 | Industrials | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Nuvation Bio
NUVB
$2.22B
| $994K | ﹤0.01% |
+340,331
| New | +$1.04M |
|
|
KALV
1577
DELISTED
KalVista Pharmaceuticals
KALV
| $990K | ﹤0.01% |
84,023
+4,658
| +6% | +$54.4K |
|
|
HLVX
1578
DELISTED
HilleVax
HLVX
| $984K | ﹤0.01% |
68,052
+6,129
| +10% | +$84.2K |
|
1579
Paycom
PAYC
$8.15B
| $983K | ﹤0.01% |
6,870
+3,308
| +93% | +$567K |
|
1580
Immunovant
IMVT
$8.06B
| $975K | ﹤0.01% |
36,929
-370,725
| -91% | -$10.5M |
|
|
WCC
1581
WESCO International
WCC
$18.2B
| $967K | ﹤0.01% |
6,098
-421
| -6% | -$71.7K |
|
1582
J.M. Smucker
SJM
$12.7B
| $965K | ﹤0.01% |
8,849
-348
| -4% | -$39.4K |
|
1583
Xeris Biopharma Holdings
XERS
$1.4B
| $950K | ﹤0.01% |
422,109
+25,164
| +6% | +$50.7K |
|
1584
Annexon
ANNX
$880M
| $948K | ﹤0.01% |
193,419
+23,849
| +14% | +$123K |
|
1585
Iovance Biotherapeutics
IOVA
$1.94B
| $942K | ﹤0.01% |
117,418
+7,199
| +7% | +$77.1K |
|
1586
EyePoint Inc
EYPT
$1.03B
| $937K | ﹤0.01% |
+107,756
| New | +$1.51M |
|
1587
Avnet
AVT
$7.97B
| $934K | ﹤0.01% |
+18,139
| New | +$929K |
|
1588
Humacyte
HUMA
$197M
| $933K | ﹤0.01% |
194,324
-3,740
| -2% | -$19.5K |
|
|
TSVT
1589
DELISTED
2seventy bio
TSVT
| $925K | ﹤0.01% |
240,367
+38,294
| +19% | +$173K |
|
1590
Xencor
XNCR
$1.47B
| $925K | ﹤0.01% |
48,870
+6,554
| +15% | +$141K |
|
1591
Kura Oncology
KURA
$817M
| $923K | ﹤0.01% |
44,849
+10,477
| +30% | +$215K |
|
1592
Trimble
TRMB
$13.7B
| $914K | ﹤0.01% |
16,337
+1,376
| +9% | +$79.4K |
|
1593
Pennant Group
PNTG
$1.35B
| $901K | ﹤0.01% |
+38,866
| New | +$852K |
|
1594
Ardelyx
ARDX
$1.21B
| $901K | ﹤0.01% |
121,599
+16,943
| +16% | +$119K |
|
1595
Mine Safety
MSA
$7.44B
| $896K | ﹤0.01% |
+4,775
| New | +$888K |
|
1596
Ultrapar
UGP
$6.69B
| $896K | ﹤0.01% |
229,175
-1,989
| -0.9% | -$9.55K |
|
1597
ALX Oncology
ALXO
$258M
| $879K | ﹤0.01% |
145,717
+18,680
| +15% | +$230K |
|
1598
BorgWarner
BWA
$13.7B
| $878K | ﹤0.01% |
27,235
-7,874
| -22% | -$273K |
|
1599
Verrica Pharmaceuticals
VRCA
$94.7M
| $874K | ﹤0.01% |
11,992
+1,753
| +17% | +$135K |
|
1600
Oric Pharmaceuticals
ORIC
$1.34B
| $868K | ﹤0.01% |
122,823
+10,850
| +10% | +$97.1K |
|
Similar funds
Wellington Management Group's Q2 2024 Portfolio in Review
As of Q2 2024, Wellington Management Group held 2,006 positions worth $560B, down 0.75% from $564B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Wellington Management Group's Q2 2024 filing shows 120 new, 834 increased, 756 reduced and 132 closed positions. Its largest new stake was Pool Corp: 1,100,398 shares worth $338M. The largest sale was Meta Platforms (Facebook), an estimated $3.04B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
- Wellington Management Group's largest Q2 2024 buy was Pool Corp: 1,100,398 shares worth $338M.
- Wellington Management Group added most to Apple in Q2 2024, an estimated $8.23B increase.
- Wellington Management Group's biggest Q2 2024 reduction was Meta Platforms (Facebook), cutting an estimated $3.04B.
- Wellington Management Group fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $850M.
- Wellington Management Group's ten largest holdings make up 24% of its $560B portfolio in Q2 2024.
- Wellington Management Group opened 120 new positions and closed 132 in Q2 2024.
- Wellington Management Group's portfolio value fell 0.75% quarter-over-quarter to $560B.
Based on Wellington Management Group's 13F filing for Q2 2024, filed 14 Aug 2024.